why is semaglutide not fda approved Warns on Certain Forms of Compounded FDA MedWatch - FDA Warns
Description
Semaglutide, used for blood sugar control in diabetes, may continue to work effectively

10.1016/j.cmet.2023.11.009 Cell Metab

Patients using semaglutide have experienced reductions in total cholesterol, LDL cholesterol, and triglycerides, likely due to its effects on weight loss and improved glycemic control

This protects them from moisture and light

Certain conditions like hypothyroidism could make weight loss more challenging

After 3 months: Liraglutide: 6% Tirzepatide: 8% After 6 months: Liraglutide: 8% Tirzepatide: 15% After 9 months: Liraglutide: 9% Tirzepatide: 18% After 1 year: Liraglutide: 9% Tirzepatide: 21% Who can take liraglutide or tirzepatide for weight loss
